Industry
Drug Manufacturers - Specialty & Generic
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.
Loading...
Open
9.56
Mkt cap
44B
Volume
7.4M
High
9.62
P/E Ratio
28.26
52-wk high
10.80
Low
9.53
Div yield
0.02
52-wk low
7.89
Portfolio Pulse from Dylan Berman
October 21, 2024 | 5:54 pm
Portfolio Pulse from Vandana Singh
October 11, 2024 | 12:57 pm
Portfolio Pulse from Kaustubh Bagalkote
October 01, 2024 | 10:25 am
Portfolio Pulse from Benzinga Newsdesk
September 30, 2024 | 6:08 pm
Portfolio Pulse from Benzinga Newsdesk
September 30, 2024 | 3:58 pm
Portfolio Pulse from Vandana Singh
September 25, 2024 | 11:18 am
Portfolio Pulse from Benzinga Newsdesk
September 20, 2024 | 12:05 pm
Portfolio Pulse from Benzinga Newsdesk
September 16, 2024 | 8:02 am
Portfolio Pulse from Benzinga Newsdesk
September 03, 2024 | 12:27 pm
Portfolio Pulse from Avi Kapoor
August 09, 2024 | 9:40 am
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.